A controversial proposal for the World Trade Organization to temporarily waive intellectual property rights and provide greater access to Covid-19 medical products appears unlikely to pass, according to people tracking the latest round of meetings at the global agency.
Despite a year-long debate, disagreement remains on the fundamental question of whether a waiver is appropriate and the most effective way to tackle inequitable distribution of Covid-19 vaccines and treatments, according to a trade official who is based in Geneva, Switzerland, where talks are being held. The WTO needs consensus from all of its 164 members for the proposal to be adopted.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
